Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Dollar Tree, Morgan Stanley, and Accenture recently announced $2.5 billion, $20 billion, and $2 billion buyback plans, respectively, totaling $24.5 billion amid a record year for S&P 500 repurchases.
US stock futures pointed higher on Monday as attention turned to a bumper week of Big Tech earnings, even with the US-Iran conflict grinding into its tenth day. Dow futures edged up 0.2%, S&P 500 contracts added 0.3%, and the Nasdaq-100 popped 0.7%, a welcome bounce after a bruising week...
The volatile energy companies are benefiting from AI-related demand and hype.
Intel has started the volume production of its client CPUs, which could help it deliver better-than-expected numbers and guidance.
Investing.com -- AMC Entertainment Holdings, Inc. (NYSE: AMC) reported second-quarter results that exceeded analyst expectations, with the company posting its highest quarterly revenue and adjusted EBITDA in its 106-year history.
AMC reported better-than-expected second-quarter earnings and massive global attendance for The Odyssey.
Jefferies has raised its price target on Arm Holdings PLC (NASDAQ:ARM) to $320 from $290, arguing that orders for the chip designer's AGI CPU have risen further since full-year results as agentic artificial intelligence fuels demand for processors. The broker repeated its 'buy' rating on the...
Grayscale highlighted Ripple's elite partnerships, yet XRP stays flat. Here is why adoption is not lifting the price.
Theater company AMC Entertainment (NYSE:AMC) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 14.2% year on year to $1.60 billion. Its non-GAAP profit of $0.14 per share was significantly above analysts’ consensus estimates.
Gas prices top $4 a gallon again, Nike loses the World Cup, SpaceX eyes data center deal, and more news to start your day.
Its technology and equipment aren't necessarily better. It's just that SpaceX shares are carrying an awful lot of baggage.
Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence across its drug discovery and development operations. The drugmaker said it will be the first life sciences company to buy an Nvidia DGX SuperPOD based on its Vera Rubin systems. The chipmaker unveiled its Vera Rubin architecture earlier this year as the successor to its current generation of AI computing systems.
Brookfield Asset Management and Canada Pension Plan Investment Board have agreed to buy LXP Industrial Trust in an all-cash deal valued at about $5.2 billion, adding a portfolio of modern warehouse and logistics facilities to their holdings.
PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend yield.
If Tom Lee is right, Ethereum could be headed to $250,000 and Bitcoin could be headed to $2 million.
KTTA, NTRS, YEXT, AEHR and STT have been added to the Zacks Rank #1 (Strong Buy) List on July 20, 2026.
The artificial intelligence trade just hit some turbulence, and chip stocks are plunging.
History shows a clear trend.
ASTS shares rose premarket as its $1 billion convertible note offering approached settlement.
Vertex Pharmaceuticals' gene therapy exagamglogene autotemcel (Casgevy) has received expanded FDA approval. The approval now includes children as young as 2 years old with sickle cell disease or transfusion-dependent thalassemia. This decision broadens treatment options for a pediatric group with limited alternatives. For investors watching NasdaqGS:VRTX, the expanded approval highlights how Vertex Pharmaceuticals is building out its rare disease franchise around genetic medicines. The...
Palantir stock is not cheap, but its growth potential remains tantalizing.
Ondas stock faces dilution concerns, but investors remain focused on defense expansion and demand amid the U.S.-Iran war.
Strategy Inc. (NASDAQ:MSTR) founder Michael Saylor made a case on Sunday against the BIP-110 software upgrade for Bitcoin (CRYPTO: BTC), arguing that the “proposed cure is more dangerous than the condition.” What Is The Upgrade About The upgrade is aimed at temporarily restricting the use of Bitcoin for storing large amounts of “non-monetary data,” including Ordinal inscriptions, and refocusing priorities on improving Bitcoin as “money.” Supporters of BIP-110 argue that this “spam” bloats the bl
Investors rotated into biotech, cybersecurity and insurance stocks with stronger growth prospects and earnings strength.
See how these popular developed and emerging markets ETFs stack up on fees, performance, and risk profiles.
Investors named Johnson & Johnson, Merck, Pfizer, AbbVie, Eli Lilly and Bristol Myers as possible bidders.
Circle remains the single-best way to get exposure to the $300 billion stablecoin industry.
Demand for memory chips to power AI workflows has led to surging prices in memory chip stocks like Micron.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
